Laddar...
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
From directly observed therapy studies, urine tenofovir (TFV) levels were 74% lower when taking tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate. Urine TFV remains quantifiable across a range of TAF adherence patterns, but a separate point-of-care lateral flow immunoassay with a lower TF...
Sparad:
| I publikationen: | Open Forum Infect Dis |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286091/ https://ncbi.nlm.nih.gov/pubmed/34285929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab200 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|